Search research articles
Contact Us
Filters
Showing results (81-90 of 86) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 86 results.
Gastroenterology
|
December 13, 2000
Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group
S Schreiber, R N Fedorak, O H Nielsen, et al.
Alimentary Pharmacology & Therapeutics
|
March 3, 2017
Clinical, endoscopic and radiographic outcomes with ustekinumab in medically-refractory Crohn's disease: real world experience from a multicentre cohort
C Ma, R N Fedorak, G G Kaplan, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie
|
March 21, 2008
Review and clinical perspectives for the use of infliximab in ulcerative colitis
R Panaccione, R N Fedorak, G Aumais, et al.
Gastroenterology
|
August 28, 1999
Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group
W J Sandborn, W J Tremaine, D C Wolf, et al.
Alimentary Pharmacology & Therapeutics
|
July 16, 2013
Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel disease
R Khanna, B D Sattin, W Afif, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie
|
November 5, 1997
The Second Canadian Consensus Conference on the Management of Patients with Gastroesophageal Reflux Disease
I T Beck, M C Champion, S Lemire, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 86) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 86 results.
Gastroenterology
|
December 13, 2000
Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group
S Schreiber, R N Fedorak, O H Nielsen, et al.
Alimentary Pharmacology & Therapeutics
|
March 3, 2017
Clinical, endoscopic and radiographic outcomes with ustekinumab in medically-refractory Crohn's disease: real world experience from a multicentre cohort
C Ma, R N Fedorak, G G Kaplan, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie
|
March 21, 2008
Review and clinical perspectives for the use of infliximab in ulcerative colitis
R Panaccione, R N Fedorak, G Aumais, et al.
Gastroenterology
|
August 28, 1999
Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group
W J Sandborn, W J Tremaine, D C Wolf, et al.
Alimentary Pharmacology & Therapeutics
|
July 16, 2013
Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel disease
R Khanna, B D Sattin, W Afif, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie
|
November 5, 1997
The Second Canadian Consensus Conference on the Management of Patients with Gastroesophageal Reflux Disease
I T Beck, M C Champion, S Lemire, et al.
Page
of 9